The estimated Net Worth of Guy J Quigley is at least $6.6 Milion dollars as of 1 October 2010. Guy Quigley owns over 5,000 units of ProPhase Labs Inc stock worth over $6,592,209 and over the last 14 years Guy sold PRPH stock worth over $5,500.
Sign up
Guy Quigley PRPH stock SEC Form 4 insiders trading
Guy has made over 1 trades of the ProPhase Labs Inc stock since 2010, according to the Form 4 filled with the SEC. Most recently Guy sold 5,000 units of PRPH stock worth $5,500 on 1 October 2010.
The largest trade Guy's ever made was selling 5,000 units of ProPhase Labs Inc stock on 1 October 2010 worth over $5,500. On average, Guy trades about 2,500 units every 0 days since 2010. As of 1 October 2010 Guy still owns at least 2,441,559 units of ProPhase Labs Inc stock.
You can see the complete history of Guy Quigley stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Guy Quigley's mailing address?
Guy's mailing address filed with the SEC is 3720 FOUNTAIN CIRCLE, , FOUNTAINVILLE, PA, 18923.
Insiders trading at ProPhase Labs Inc
Over the last 15 years, insiders at ProPhase Labs Inc have traded over $6,868,501 worth of ProPhase Labs Inc stock and bought 2,996,691 units worth $4,189,802 . The most active insiders traders include Braden Michael Leonard, Ted William Karkus a James T Mccubbin. On average, ProPhase Labs Inc executives and independent directors trade stock every 98 days with the average trade being worth of $586,896. The most recent stock trade was executed by Ted William Karkus on 1 February 2023, trading 500,000 units of PRPH stock currently worth $300,000.
What does ProPhase Labs Inc do?
prophase labs is a diversified natural health medical science company. for more information visit us at www.prophaselabs.com.
What does ProPhase Labs Inc's logo look like?
Complete history of Guy Quigley stock trades at ProPhase Labs Inc
ProPhase Labs Inc executives and stock owners
ProPhase Labs Inc executives and other stock owners filed with the SEC include:
-
Ted William Karkus,
Chairman & CEO -
Monica Brady,
Chief Financial Officer -
Ted Karkus,
Chairman of the Board, Chief Executive Officer -
Monica Brady,
Chief Financial Officer -
Warren Hirsch,
Independent Director -
Louis Gleckel,
Independent Director -
Jason Barr,
Independent Director -
Sergio Miralles,
Exec. VP & Chief Information Officer of ProPhase Diagnostics -
Sam A. Beeler,
Chief Strategy Officer of Precision Medicine -
Jason Karkus,
Exec. VP & Co-COO -
Alice Lioi,
Exec. VP & Co-COO -
Mark S Leventhal,
Director -
Mark Shawn Frank,
Director -
James T Mccubbin,
Director -
Mark A. Burnett,
Director -
Braden Michael Leonard,
10% owner -
Guy J Quigley,
10% owner -
Robert V Jr Cuddihy,
Chief Operating Officer -
John De Shazo,
Director -
Jed Latkin,
Director -
Robert A. Jr. Morse,
CHIEF FINANCIAL OFFICER